Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Jan 29;47(2):e62. doi: 10.1016/j.ejso.2020.11.309

Trend to escape preoperative X-ray therapy with the aim to avoid concomitant COVID risks

Sergii Podpriatov 1, Sergiy Podpryatov 1, Vitaliy Ivakha 1, Ihor Belousov 1, Vitaliy Korchak 2
PMCID: PMC7845512

Background: COVID-19 pandemy brought the risks to interrupt the combined oncological therapy during its stages.

Materials and Methods: The trends in patient’s habitués were analyzed. The 5 colorectal, 2 prostates, 1 urine bladder, 1 penile and 1 mammary cancer had been found at ambulatory during COVID-19 quarantine. Weakness duration in all of these patients exceeded 3-7 months, comparatively to similar patients before quarantine period. Only 3 patients come at stage 1-2 disease: with prostate (1), urinary bladder (1) and colon (1) cancer, and 1 patient has colon cancer at stage 3. Other patients come at 4 stage, all complicated. The reason for delay was patient’s unwillingness to visit a doctor.

Results: One patient was denied of surgery through the bad general status, 9 operated on, four of them by emergency. The common for colorectal cases is trend to avoid the preoperative X-ray therapy and concomitant COVID risks. Any patient was infected with COVID during perioperative period. One patient died because of preoperative cancer complications after urgent surgery. Others preserved wounds, plasty flaps and got conventional chemotherapy. Any local relapse manifestations were observed during 2-7 months.

Conclusions: At the time of COVID some cancer patients refrain from in-time medical aid for psychological reasons. Trend to escape preoperative X-ray therapy with the aim to avoid concomitant COVID risks, especially concerning complicated psychological background, should be discussed.

ESSO20V-0139


Articles from European Journal of Surgical Oncology are provided here courtesy of Elsevier

RESOURCES